Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16117816rdf:typepubmed:Citationlld:pubmed
pubmed-article:16117816lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C0205359lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C0695347lld:lifeskim
pubmed-article:16117816lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:16117816pubmed:issue3lld:pubmed
pubmed-article:16117816pubmed:dateCreated2005-8-24lld:pubmed
pubmed-article:16117816pubmed:abstractTextThree major therapeutic modalities (transsphenoidal surgery, radiotherapy and medical therapy) are currently available for acromegaly. Although surgery is regarded as the primary option, 50--60% of macroadenomas require further treatment in the form of radiotherapy and/or medical therapy. Recent studies have suggested that radiotherapy might damage the normal hypothalamic-pituitary axis and also rarely leads to IGF-I normalization. The aims of this study were: (1) to examine the effect of different therapeutic modalities (transsphenoidal surgery, TSS; radiotherapy, RT; medical treatment with somatostatin analogues, SSA) on the daily spontaneous GH secretory pattern (day curve); and (2) to determine the relationship between the characteristics of the GH secretory pattern and the circulating concentration of IGF-I, acid-labile subunit (ALS) and IGFBP-3.lld:pubmed
pubmed-article:16117816pubmed:languageenglld:pubmed
pubmed-article:16117816pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:citationSubsetIMlld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16117816pubmed:statusMEDLINElld:pubmed
pubmed-article:16117816pubmed:monthSeplld:pubmed
pubmed-article:16117816pubmed:issn0300-0664lld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:BarrecaAntoni...lld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:GiustiMassimo...lld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:FeroneDiegoDlld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:MinutoFrances...lld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:SidotiMarilen...lld:pubmed
pubmed-article:16117816pubmed:authorpubmed-author:ResminiEugeni...lld:pubmed
pubmed-article:16117816pubmed:issnTypePrintlld:pubmed
pubmed-article:16117816pubmed:volume63lld:pubmed
pubmed-article:16117816pubmed:ownerNLMlld:pubmed
pubmed-article:16117816pubmed:authorsCompleteYlld:pubmed
pubmed-article:16117816pubmed:pagination294-7lld:pubmed
pubmed-article:16117816pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:meshHeadingpubmed-meshheading:16117816...lld:pubmed
pubmed-article:16117816pubmed:year2005lld:pubmed
pubmed-article:16117816pubmed:articleTitleEffect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients.lld:pubmed
pubmed-article:16117816pubmed:affiliationDepartment of Endocrinological and Metabolic Sciences, University of Genova, Genova, Italy.lld:pubmed
pubmed-article:16117816pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16117816pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16117816pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed